Concepedia
Statistics
Publications
6
Citations
371
H-Index
Active since
2015
Affiliations
de Duve Institute(Current)
Ludwig Cancer Research
Walloon Excellence in Lifesciences and Biotechnology
Bone Therapeutics
Delia Hoffmann is an author at de Duve Institute specializing in indoleamine 2, 3-dioxygenase pathway, immunology, and medicine.
Publications per year
2015–2021
Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance
Marc Hennequart, Luc Pilotte, Stefania Canè et al. · Cancer Immunology Research · 2017 · 173 citations
Medicine, Immunology, Oncology +13
Inhibition of Tryptophan-Dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors
Florence Schramme, Stefano Crosignani, Kim Frederix et al. · Cancer Immunology Research · 2019 · 69 citations · Full text
Medicine, Oncology, Pharmacology +17
Tryptophan 2,3-Dioxygenase Expression Identified in Human Hepatocellular Carcinoma Cells and in Intratumoral Pericytes of Most Cancers
Delia Hoffmann, Tereza Dvořáková, Vincent Stroobant et al. · Cancer Immunology Research · 2019 · 57 citations · Full text
Medicine, Cancer Biology, Oncology +13
Regulation of Macrophage Motility by the Water Channel Aquaporin-1: Crucial Role of M0/M2 Phenotype Switch
Donatienne Tyteca, Tomoya Nishino, Huguette Debaix et al. · PLoS ONE · 2015 · 43 citations · Full text
Life Sciences, Cell Biology, Immunology +17
Tryptophanemia is controlled by a tryptophan-sensing mechanism ubiquitinating tryptophan 2,3-dioxygenase
Simon Klaessens, Vincent Stroobant, Delia Hoffmann et al. · Proceedings of the National Academy of Sciences · 2021 · 19 citations · Full text
Life Sciences, Biochemistry, Immunology +15
1–5 of 6